EDITORIAL
Published on 14 Jun 2022
Editorial: Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
doi 10.3389/fphar.2022.927812
- 1,836 views
- Frontiers in Pharmacology
- Neuropharmacology
- Research Topics
- Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
Intranasal Delivery of Central Nervous System Active Drugs: Opportunities and Challenges
7,232
Total downloads
27k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 24 Mar 2022
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
doi 10.3389/fphar.2022.865590
- 6,679 views
- 14 citations
ORIGINAL RESEARCH
Published on 14 Feb 2022
Intranasal Delivery of Galanin 2 and Neuropeptide Y1 Agonists Enhanced Spatial Memory Performance and Neuronal Precursor Cells Proliferation in the Dorsal Hippocampus in Rats
doi 10.3389/fphar.2022.820210
- 2,269 views
- 14 citations
ORIGINAL RESEARCH
Published on 28 Jan 2022
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington’s Disease Models: Role of PAC1 Receptor
doi 10.3389/fphar.2021.797541
- 2,486 views
- 11 citations
ORIGINAL RESEARCH
Published on 12 Jul 2021
Current State and Future Directions of Intranasal Delivery Route for Central Nervous System Disorders: A Scientometric and Visualization Analysis
doi 10.3389/fphar.2021.717192
- 5,716 views
- 62 citations
ORIGINAL RESEARCH
Published on 18 Sep 2020
Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
doi 10.3389/fphar.2020.576624
- 5,139 views
- 8 citations
Published in
Frontiers in Pharmacology
- Neuropharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.2 citescore
Impact
- 27kTopic views
- 19kArticle views
- 7,232Article downloads